Human and mouse granulocyte-macrophage-colony-stimulating factors (hGM-CSF and mGM-CSF, respectively), isolated from Escherichia coli cells expressing the corresponding human and mouse genes, have been characterized. The observed properties of the proteins have been compared with those properties which can be deduced from the DNA sequence alone and the published properties of natural GM-CSFs. The purified E. coli-derived proteins were found to have the expected molecular masses, amino acid compositions and N-and C-terminal amino acid sequences. The finding of 70-90 % unprocessed N-terminal methionine for both proteins is discussed. The four Cys residues were found to be involved in two intramolecular disulphide bonds, linking the first and third, and second and fourth Cys residues. This disulphide bond arrangement is probably the one existing in natural material, since, although not glycosylated, both E. coliderived proteins showed biological activity (colony stimulating assay for hGM-CSF, and cell proliferation assay for mGM-CSF) comparable with that reported for the respective proteins purified from animal cells.
INTRODUCTION
The differentiation, activation and proliferation of the various blood cells arising from multi-potential stem cells are controlled by a group of glycoproteins synthesized by multiple cell types distributed in many tissues [1, 2] . One such factor which regulates the formation of granulocytes and macrophages has been termed GM-CSF. Both the human [3] and mouse [4] proteins have been isolated, and the nucleotide sequences encoding the proteins determined [5, 6] . Initial studies have indicated that these factors appear to play an important role in the control of haematopoiesis [2] ; however, such studies have been limited by the unavailability of pure and wellcharacterized proteins. As a result of the expression of the human [7] and mouse [8] GM-CSFs in E. coli, sufficient material is now available for biological and structural studies. The following report describes the characterization of biologically active hGM-CSF and mGM-CSF.
MATERIALS AND METHODS Chemicals
Protein standards for gel filtration (low Mr range) and for isoelectric focusing (pI ranges 3-10 and 2.5-6.5) were obtained from Pharmacia. All other chemicals used were of reagent grade or better.
Purification of proteins
The human and mouse GM-CSF proteins were both expressed in E. coli as insoluble aggregates [7, 8] . The proteins were solubilized with 6 M-guanidine hydrochloride as described for recombinant-derived mGM-CSF [8] and renatured by equilibrium dialysis against a non-denaturing (3 M) concentration of urea (see [9] for rationale). The proteins were purified by anion-exchange chromatography using Fast Flow Q (Pharmacia) and gel filtration using Ultrogel AcA54 (LKB).
Protein determination
Molar absorbance coefficients (e) for the proteins were calculated from the amino acid composition according to the procedure of Wetlaufer [10] . The values for hGM-CSF and mGM-CSF are 14.04 mm-cm-and 10.98 mm cm-' respectively and are based on the respective Mr values of 14650 and 14347 [5, 6] .
Analytical separation methods
Gel electrophoresis in the presence of SDS was carried out on 15 % polyacrylamide gels using the procedure of Laemmli [11] . The proteins were visualized by either Coomassie Blue or silver staining [12] . Electrofocusing was carried out on thin-layer polyacrylamide gels (LKB Ampholine PAG plates pH 3.5-9.5) according to the protocol of the manufacturer. H.p.l.c. was performed on a system which has previously been described [13] except that the manual injector has been replaced by an automatic one (Wisp model 710B, Waters). A C18 Radialpak ,uBondapak column was used in a Z module at a flow rate of 1 ml min-'. Solvent A was I g trifluoroacetic acid (h.p.l.c. grade, Pierce) dissolved in 1 litre h.p.l.c. grade water (MilliQ system, Millipore). Solvent B was pure acetonitrile (h.p.l.c. grade, Merck). The column, equilibrated with solvent A, was eluted isocratically for 5 min after sample injection, then a Vol. 247 Abbreviations used: hGM-CSF and mGM-CSF, human and mouse granulocyte-macrophage-colony-stimulating factor respectively. t To whom correspondence and reprint requests should be addressed. linear gradient of solvent B was applied (0.5 %/min for protein digests, to 60 % B; 1 %/min for isolated peptides reduced with dithiothreitol). Samples were acidified with acetic acid prior to injection. Reduction and alkylation of protein Dithiothreitol (5 mM; i.e. 10 mM-SH) was added to a nitrogen-purged solution of protein (1-2 mg ml-') which was 150 mm in Tris/HCl, pH 8.3, 2 mm in EDTA, and 3 M in guanidine hydrochloride. The solution was incubated for 1 h at 22°C, then iodoacetamide was added to a concentration of 15 mm. After 30 min at 22°C in the dark, a further 5 mm dithiothreitol was added and the solution dialysed against 5 mM-NH4HCO3 and lyophilized.
Amino acid analysis
Reduced and alkylated proteins were hydrolysed in constant-boiling HCI at 110°C for 24, 48 and 72 h in nitrogen-purged evacuated tubes in the presence of phenol (1 mg ml-') and 100 mM-ethanethiol. Peptides isolated by h.p.l.c. were hydrolysed for 24 h without scavengers. Hydrolysates were analysed on a Beckman 6300 amino acid analyser. The tryptophan content of the proteins was determined by ultraviolet absorption spectroscopy in the presence of 6 M-guanidine hydrochloride as described by Edelhoch [14] . Thiol and disulphide analysis The proteins were analysed for thiol and for disulphide bonds as previously described ([15] and [16] , respectively).
Location of disulphide bonds
Samples of native protein (about 5 mg/ml) were treated with CNBr (2.5 or 5 mg/ml for h and mGM-CSF, respectively) in 70 % (v/v) formic acid at 22°C for 24 h. After removal of reagent and solvent under high vacuum, samples were digested (hGM-CSF with Staphylococcus aureus protease V8 and mGM-CSF with trypsin and V8). Digests were examined by analytical h.p.l.c., with and without reduction [50 mM-dithiothreitol in 0.5 % (w/v) NH4HCO3, 37°C, 2 h] prior to chromatography. Peaks which were found to be susceptible to reduction were collected separately in a preparative run of unreduced material, then each was subjected to reduction and rechromatography. The reduced peaks thus isolated were hydrolysed and analysed on the amino acid analyser. N-terminal and C-terminal sequence analysis Edman degradation was performed with a gas-phase sequencer (Applied Biosystems). Identification and quantification of amino acid phenylthiohydantoins was by reversed phase h.p.l.c. with an external standard for quantification. C-Terminal sequence analysis of mGM-CSF was performed by the combined gas-liquid chromatography-mass spectrometry method [17] . C line as described [18] (and references cited therein). Purified mGM-CSF was assayed by the cell proliferation assay [8] using the factor-dependent mouse cell line FDC-P1. In both assays, GM-CSF-dependent growth was quantified by scintillation counting of [3H]thymidine incorporated into the cells after incubation of the cells with serial dilutions of the respective GM-CSF. Activity of the recombinant GM-CSFs is expressed as the concentration of the protein which gave one-half the maximum incorporation of [3H]thymidine. RESULTS 
AND DISCUSSION Size and charge homogeneity
The results of SDS-gel electrophoresis of the E. coliderived GM-CSFs are shown in Fig. 1 . Single bands for both proteins are evident, with estimated Mr values similar to those predicted by the gene sequences (14650 and 14347 for hGM-CSF and mGM-CSF, respectively). No contaminating E. coli proteins were detected by either Coomassie Blue or silver staining. Samples pretreated with SDS in the absence of the reductant (dithiothreitol) gave similar results, indicating the absence of intermolecular disulphide cross-linked protein.
The proteins behaved as monomers of expected Mr upon gel filtration on Ultrogel AcA54 in phosphate-buffered saline, pH 7.5 (results not shown).
Densitometric scanning of hGM-CSF and mGM-CSF separated by isoelectric focusing on a polyacrylamide gel stained with Coomassie Blue (Fig. 1 ) indicated main species constituting 97 % and 93 % respectively of the total protein. The minor species observed are probably charge derivatives of the GM-CSF proteins since, as aforementioned, only single bands were observed by SDS-gel electrophoresis (Fig. 1) . The experimental pI values of the main species, namely 5.3 and 6.0 for hGM-CSF and mGM-CSF respectively, were very similar to those predicted from the amino acid composition using a [20] . The proximity of Pro in the N-terminal sequence Met-Ala-Pro-is probably responsible for the reluctance to cleave the initiating Met, as was proposed for the case of recombinant-derived interleukin-2 [21] . It has since been found that, under some circumstances, the initiator Met may be removed from this latter protein [22] , and we find that Met is removed from E. coli-derived GM-CSFs to the extent of 10-30 %. The proximity of Pro would thus seem to hinder Met removal rather than prevent it. (11) 3.97 (4) 6.99 (7) 1.01 (1) 10.96 (11) 4.00 (4) 0.75 (1) Carboxypeptidase A digestion of hGM-CSF showed release of only Glu and either Asn or Gln (these latter two amino acids are difficult to resolve using our analyser). Carboxypeptidase Y also released Glu and Asn/Gln in approximately a 1: 1 molar ratio, followed by slower release of Val (data not shown). These results lead to the sequence assignment -Val-(Asn/Gln,Glu)-OH, which is consistent with the sequence predicted from the gene sequence, namely -Pro-Val-Gln-Glu-OH. Since the sequence -Val-(Asn/Gln,Glu)-appears once only and at the C-terminus in the predicted amino acid sequence of hGM-CSF (Fig. 2) , it is reasonable to deduce that the protein, as isolated, terminates with -Val-Gln-Glu-OH, as expected. The C-terminal amino acid sequence of the mouse protein was determined by mass spectrometry to be -Val-Gln-Lys-OH (results not shown), which is the sequence expected from the gene sequence (Fig. 2) .
Disulphide bonds
The four cysteine residues present in each protein were non-titratable with 5,5'-dithiobis-(2-nitrobenzoic acid), -.indicating the presence of two disulphide bonds per molecule. This was confirmed by the direct assay for disulphides (see the Materials and methods section), which indicated 1.97 and 2.02 disulphides per molecule for hGM-CSF and mGM-CSF, respectively.
The two major peaks of absorbance eluting during h.p.l.c. analysis of digested hGM-CSF were found to be susceptible to reduction with dithiothreitol (results not shown). Isolation of these two peaks (peaks 14 and 18 in order of elution, monitoring at 214 nm) followed by their reduction and rechromatography yielded the results shown in Fig. 3 . Both of the original peaks gave rise to two new peaks, presumably via reductive cleavage of a disulphide bond: peak 14 gave rise to peaks 14i and 14ii (Fig. 3a) , and peak 18 gave rise to 18i and 18iii (Fig. 3b) . Peak 18i exhibited tailing, a feature quite common for peptides treated with cyanogen bromide and usually associated with partial deamidation. Amino acid analysis of the resulting fractions gave the results shown in Table  1 . Fractions 14i, 14ii, 18i and 18iii correspond to residues 95-105, 48-61, 81-94 and 110-128, respectively. Fraction 18ii is seen to have essentially the same composition as 18i, consistent with its being associated with deamidation. Good agreement (Table 1) is found between the compositions of the recovered peptides and the compositions expected if disulphide bonds were to link the first and third, and second and fourth Cys residues (see Fig.  2 ). No other arrangement of the disulphide bonds is consistent with the amino acid compositions.
A similar result was obtained upon h.p.l.c. analysis of digested mGM-CSF (results not shown). The major component of the digest (CNBr followed by trypsin and V8) was reducible with dithiothreitol to give two new peaks (called 19i and l9ii). Amino acid analysis of these reduced peptides gave the results shown in Table 1 . See  Fig. 2 for the sequence of mGM-CSF. Peptide 19i corresponds to residues 73-91, liberated by the activity of trypsin at Lys-72 and of V8 at Glu-91. The failure of CNBr to cleave the sequence Met-Thr (residues 77-78) is not unusual. Peptide l9ii corresponds to residues 110-120, liberated--by the activity of trypsin at Lys-109 and Lys-120. Failure of V8 to cleave the sequence Glu-hys is attributed to steric hindrance due to the disulphide bond which was intact during the enzymic digestion. From the results of these experiments, we are led to conclude that Cys-86 is joined by a disulphide bond to Cys-119 in native mGM-CSF. Since no free thiol groups were detected, the other two Cys residues, at positions 52 and 94, must be connected by a disulphide bond. No other arrangement of disulphide bonds is consistent with amino acid compositions of peptides 19i and l9ii. This arrangement of disulphide bonds, first to third and second to fourth, is the same as that determined above for the protein of human sequence. As discussed above, both hGM-CSF and mGM-CSF samples were, after cleavage with CNBr, digested -with enzymes under mildly alkaline conditions (in a trial experiment, it had proved impossible to digest CNBrcleaved mGM-CSF with V8 at pH 4). There exists therefore the possibility that disulphide bond scrambling took place during digestion. For the following reasons, we believe that such scrambling is unlikely. 
Biological activity
The assays of the E. coli-derived GM-CSFs for biological activity, as described in the Materials and methods section, showed that both the mouse and the human proteins were highly active. The concentrations which produced half-maximal stimulation in the corresponding assays were 1.0 x 10-12 M for hGM-CSF (S.D. + 0.6 x 10-12, n = 4) and 6.7 x 10-12 M for mGM-CSF (S.D. + 3.9 x 10-12, n = 8). These values are comparable with those described for the respective proteins purified from animal cells [3, 4] .
CONCLUSION
For both hGM-CSF and mGM-CSF, E. coli-derived material was found to be similar in chemical structure and biological activity to what is expected or reported for material derived from animal cells [2, 5, 18] . Differences in chemical structure between natural and recombinantderived proteins (i.e. the lack of glycosylation and the presence of initiating methionine for the E. coli-derived proteins) were due to differences in post-translational modification, as was found to be the case for interleukin-2 [21] . The fact that the E. coli-derived GM-CSFs, although lacking glycosylation and possessing an initiating methionine, are about as active as natural material, suggests that the disulphide bond arrangement determined here is probably the one existing in natural material. The availability of large amounts of pure recombinant-derived GM-CSF will hopefully allow its clinical value in the regeneration of haemopoietic tissue and in the treatment of infectious and myeloid leukaemia to be fully assessed.
